Seth H. Z. Fischer - 21 Mar 2023 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
21 Mar 2023
Net transactions value
$0
Form type
4
Filing time
23 Mar 2023, 19:33:36 UTC
Previous filing
08 Feb 2023
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Stock Option (right to buy) Award $0 +42,000 $0.000000 42,000 21 Mar 2023 Common Shares 42,000 $3.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in equal monthly installments, beginning on April 21, 2023, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date.